public beta · research use only

EVIDENCE. IN THE OPEN.

An open hub for AI-generated peptide candidates. Every sequence gets a card. Every card ships with a recipe. Every fork is traceable.

cards 1739
targets 64
authors 1
reproduced 223

PeptideModel is an open research database for AI-generated peptide candidates. Every entry follows a five-level evidence pipeline — designed, computed, reproduced, synthesized, and bioassayed — that distinguishes AI proposals from experimentally validated sequences. Each card records the full prediction recipe (model, version, hardware, seeds, command) for independent reproducibility. All data is CC-BY-SA 4.0 and accessible via a free public API at api.peptidemodel.com. The platform currently indexes 1739 sequences across 64 biological targets.

Semaglutide FLAGSHIP weight loss & type-2 diabetes BPC-157 FLAGSHIP gut healing & tissue repair DF-3 ADVANCED muscle growth GIP (1-30) FLAGSHIP insulin release, obesity treatment Melanotan I FLAGSHIP skin darkening & sun-pain protection Tirzepatide ADVANCED weight loss & type-2 diabetes Retatrutide FLAGSHIP weight loss & metabolism TB-500 FLAGSHIP tissue repair & angiogenesis Oxytocin ADVANCED labor & social bonding CJC-1295 FLAGSHIP growth hormone release Setmelanotide ADVANCED genetic obesity treatment Sermorelin ADVANCED stimulates growth hormone release Cagrilintide NEWS appetite suppression & weight loss LL-37 ADVANCED kills bacteria & pathogens Elamipretide NEWS stabilizes cellular energy production MOTS-c ADVANCED energy metabolism & longevity Semaglutide FLAGSHIP weight loss & type-2 diabetes BPC-157 FLAGSHIP gut healing & tissue repair DF-3 ADVANCED muscle growth GIP (1-30) FLAGSHIP insulin release, obesity treatment Melanotan I FLAGSHIP skin darkening & sun-pain protection Tirzepatide ADVANCED weight loss & type-2 diabetes Retatrutide FLAGSHIP weight loss & metabolism TB-500 FLAGSHIP tissue repair & angiogenesis Oxytocin ADVANCED labor & social bonding CJC-1295 FLAGSHIP growth hormone release Setmelanotide ADVANCED genetic obesity treatment Sermorelin ADVANCED stimulates growth hormone release Cagrilintide NEWS appetite suppression & weight loss LL-37 ADVANCED kills bacteria & pathogens Elamipretide NEWS stabilizes cellular energy production MOTS-c ADVANCED energy metabolism & longevity

trending this week · by activity

view all trending →

latest news · original reporting

view all news →
One daily PTH shot held for five years, a weekly rival posted its first
At ENDO 2026, Ascendis's once-daily palopegteriparatide posted 82 percent responders at five years while MBX's once-weekly canvuparatide hit 57 percent at one year. Two precision PTH peptides for a condition stuck on daily calcium pills for two decades.
PTH1R
A woman restarted semaglutide at the top dose and ruptured her esophagus
The first documented case of Boerhaave's syndrome tied to a GLP-1 drug followed a restart at the maximum 2.4 mg dose with no titration, a flag for the common pause-and-resume pattern.
GLP-1R

browse by target · 53 targets indexed

all targets →

The grid of family cards becomes a body-map on-ramp. Pick a system — by tab, by the figure, or by the index — and the panel resolves to that region's targets, ranked by activity, one click from the full list.

view anterior · male · icon-led systems · mapped rig

how it works · platform pipeline · all cards

read the protocol →
1designed
1,739100.0%
2computed
1,71298.4%
3reproduced
42224.3%
4synthesized
42124.2%
5bioassayed
25414.6%

Every card carries a five-level status. Anyone can design; computation and reproduction require a recipe and attached artifacts; synthesis requires an LC-MS spectrum; assay requires a protocol and raw data. The funnel is steep because the schema is strict — and that's the point.

recent activity · live feed across all targets

open full activity →
loading…